GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

SXTP · Mar 31, 2026

60 DEGREES PHARMACEUTICALS, INC.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001554855-26-001058General Corporate
Debt relative to revenue45thOwn-history percentile · N=11
Evidence method

Level · gp.fundamentals.debt_to_revenue

92.56% · OPTIONAL · VALID

Capex intensityRAWCurrent state valid · history insufficient
Evidence method

Level · gp.fundamentals.capex_revenue_ratio

18.51% · OPTIONAL · NOT_ENOUGH_HISTORY

Operating cash generation20thOwn-history percentile · N=10
Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

-1691.36% · OPTIONAL · VALID

Revenue growthRAWCurrent state valid · history insufficient
Evidence method

Yoy · gp.fundamentals.revenue

-0.89% · CORE · NOT_ENOUGH_HISTORY

Inventory pressure73thOwn-history percentile · N=11
Evidence method

Level · gp.fundamentals.inventory_revenue_ratio

561.78% · OPTIONAL · VALID

Gross margin78thOwn-history percentile · N=9
Evidence method

Level · gp.fundamentals.gross_margin

47.12% · CORE · VALID

Operating margin64thOwn-history percentile · N=11
Evidence method

Level · gp.fundamentals.operating_margin

-1292.45% · CORE · VALID

R&D intensity0thOwn-history percentile · N=11
Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

173.64% · OPTIONAL · VALID

SBC intensity20thOwn-history percentile · N=10
Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

76.56% · OPTIONAL · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History11 statesHistory building
Period transition

What moved in the state?

Balance Sheet Leverage Increased
Previous
14.92%
Current
92.56%
Delta
77.64%
Capex Intensity Increased
Previous
13.91%
Current
18.51%
Delta
4.60%
Cash Generation Decreased
Previous
-681.18%
Current
-1691.36%
Delta
-1010.18%
Growth Decreased
Previous
65.49%
Current
-0.89%
Delta
-66.38%
Inventory Pressure Increased
Previous
65.33%
Current
561.78%
Delta
496.45%
Margin Increased
Previous
22.26%
Current
47.12%
Delta
24.86%
Profitability Decreased
Previous
-771.64%
Current
-1292.45%
Delta
-520.82%
R And D Intensity Decreased
Previous
209.47%
Current
173.64%
Delta
-35.83%
Sbc Intensity Increased
Previous
45.39%
Current
76.56%
Delta
31.18%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.